KW 2449,
KW-2449,
KW2449,
KW-2449,
1000669-72-6,
KW 2449,
KW2449,
UNII-2D9N67F58G,
CHEMBL1908397,
2D9N67F58G,
(E)-(4-(2-(1H-Indazol-3-yl)vinyl)-phenyl)(piperazin-1-yl)methanone,
(E)-(4-(2-(1H-indazol-3-yl)vinyl)phenyl)(piperazin-1-yl)methanone,
J-502761,
[4-[2-(1H-Indazol-3-yl)ethenyl]phenyl]-1-piperazinylmethanone,
[4-[(E)-2-(1H-indazol-3-yl)ethenyl]phenyl]-piperazin-1-ylmethanone,
Methanone, (4-(2-(1H-indazol-3-yl)ethenyl)phenyl)-1-piperazinyl-,
Methanone, [4-[2-(1H-indazol-3-yl)ethenyl]phenyl]-1-piperazinyl-,
YYLKKYCXAOBSRM-JXMROGBWSA-N,
(E)-(4-(2-(1H-Indazol-3-yl)vinyl)phenyl)(piperazin-1-yl)methanone hydrochloride,
KW-2449 Hydrochloride,
MLS006011271,
GTPL5691,
SCHEMBL1596894,
SCHEMBL1596897,
CHEBI:91441,
BCP02848,
EX-A2306,
BDBM50355496,
MFCD18385006,
s2158,
ZINC43201999,
AKOS027460993,
BCP9000826,
CS-0231,
RL00013,
SB19381,
NCGC00346569-07,
841258-76-2,
AC-28419,
HY-10339,
SMR004703021,
SW219852-1,
X7371,
W-5753,
(E)-1-{4-[2-(1H-indazol-3-yl)vinyl]benzoyl}piperazine,
1000669-72-6 , KW 2449, KW-2449,
3-[(E)-2-[4-(piperazine-1-carbonyl)phenyl]ethenyl]-1H-indazole,
Piperazine, 1-(4-((1E)-2-(1H-indazol-3-yl)ethenyl)benzoyl)-,
(4-((1E)-2-(1H-Indazol-3-yl)ethenyl)phenyl)-1-piperazinylmethanone,
3-[(E)-2-{4-[(piperazin-1-yl)carbonyl]phenyl}ethenyl]-2H-indazole,
841259-17-4,
D00ABO,
cc-533,
C20H20N4O,
CID11427553,
Tumor antigen-specific mAb (cancer), Kyowa,
A10508,
[4-[(1E)-2-(1H-Indazol-3-yl)ethenyl]phenyl]-1-piperazinylmethanone,
[4-[(E)-2-(1H-indazol-3-yl)ethenyl]phenyl]-piperazin-1-yl-methanone,
Tumor antigen-specific monoclonal antibody (cancer), Kyowa Hakko Kirin,
Tumor antigen-specific monoclonal antibody (cancer), Kyowa Hakko Kogyo,